AstraZeneca drags down FTSE 100

AstraZeneca drags down FTSE 100
 

Drugmaker AstraZeneca has seen its share price plummet more than 15% after announcing disappointing results.
The firm said first-quarter revenue fell 10% to $5.05bn (£3.84bn).
It also reported a major setback in trials of a new lung cancer drug therapy.
The company was by far the biggest loser on the benchmark FTSE 100 share index, which was down 5.99 points, or 0.08%, to 7,446.33 in early Thursday trading.
In the currency market, the pound edged higher against the dollar, up 0.12% at $1.3138. Against the euro, the pound was 0.29% higher at 1.1204 euros.
read more

 
27 July 2017 in Business, Views: 52
Source: BBC
Share:
 




News Widget for Webmasters


Realtime News

 

«
»
Mo Tu We Th Fr Sa Su
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31